Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing …

IRVINE, CA , Jan. 31, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that the Company’s research team is expanding the scope of its current cancer research to include Leukemia.

Read More

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.